Skip to content

Investors

November 2, 2023

Conference call on 3rd quarter 2023 results

Learn more

Virtual Capital Markets Day 2023

The event took place on April 19, 2023.

 

Learn more

About us

Sustainability

Global Sustainability Program
Management Board Targets
Corporate Governance
Human Capital
2022 Non-Financial Group Report
SASB Index
GRI Index
TCFD Index
ESG Performance Data

Learn more

Reports and financials

Publications

Find out more details in our annual and quarterly reports, presentations and webcasts.Visit also our Facts & Figures 2022 page.

Learn more
| Reporting

Report on 4th quarter 2023: Earnings Release and Conference Call

Save the date
| Reporting

Financial statements 2023

Save the date
| Reporting

Report on 1st quarter 2024: Earnings Release and Conference Call

Save the date
| Reporting

Quarterly financial report within the first half year (Q1)

Save the date
| Virtual Conference

Bank of America Virtual Home Care Conference

Save the date
| Investor conference

Berenberg European conference

Pennyhill
Save the date
| Roadshow

Roadshow with Société Générale

Tokyo
Save the date
| Press release
Fresenius Medical Care completes change of legal form into a German stock corporation
| Press release
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement today, whereby the company will receive a payment from the U.S. government.
| Press release
Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter
| Press release
Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery

Investors

Meet the Management

Learn more

Investors

Extraordinary General Meeting 2023

Learn more
Contact us for further information
+49 6172 609 2525
Contact Investor Relations

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to
ir(at)fmc-ag.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our 
privacy policy.

newsletter registration
captcha